T2 Biosystems Inc. (NASDAQ: TTOO)
$0.8900
-0.0600 ( -6.32% ) 265.4K
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Market Data
Open
$0.8900
Previous close
$0.9500
Volume
265.4K
Market cap
$15.56M
Day range
$0.8850 - $0.9650
52 week range
$0.8850 - $8.3799
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 19 | May 20, 2024 |
8-k | 8K-related | 13 | May 14, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
4 | Insider transactions | 1 | May 07, 2024 |
8-k | 8K-related | 13 | May 07, 2024 |
8-k | 8K-related | 18 | May 06, 2024 |
10-q | Quarterly Reports | 76 | May 06, 2024 |
8-k | 8K-related | 15 | Apr 18, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
8-k | 8K-related | 13 | Apr 12, 2024 |